EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Transforming growth factor-β (TGF-β) signaling pathway-related genes in predicting the prognosis of colon cancer and guiding immunotherapy

Jie Chen, Chao Ji, Silin Liu, Jin Wang, Che Wang, Jue Pan, Jinyu Qiao, Yu Liang, Mengjiao Cai, Jinlu Ma

Cancer Pathogenesis and Therapy · 2024-10 · 2 (4) · 299-313

DOI: 10.1016/j.cpt.2023.12.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Pathogenesis and Therapy, 2024-10. Verfasst von Jie Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Xi’an Jiaotong University, Fundamental Research Funds for the Central Universities, Huazhong University of Science and Technology Tongji Medical College Union Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Colon cancer is a malignant tumor with high malignancy and a low survival rate whose heterogeneity limits systemic immunotherapy. Transforming growth factor-β (TGF-β) signaling pathway-related genes are associated with multiple tumors, but their role in prognosis prediction and tumor microenvironment (TME) regulation in colon cancer is poorly understood. Using bioinformatics, this study aimed to construct a risk prediction signature for colon cancer, which may provide a means for developing new effective treatment strategies.

Methods

Using consensus clustering, patients in The Cancer Genome Atlas (TCGA) with colon adenocarcinoma were classified into several subtypes based on the expression of TGF-β signaling pathway-related genes, and differences in survival, molecular, and immunological TME characteristics and drug sensitivity were examined in each subtype. Ten genes that make up a TGF-β-related predictive signature were found by least absolute shrinkage and selector operation (LASSO) regression using colon cancer data from the TCGA database and confirmed using a Gene Expression Omnibus (GEO) dataset. A nomogram incorporating risk scores and clinicopathologic factors was developed to stratify the prognosis of patients with colon cancer for accurate clinical diagnosis and therapy.

Results

Two TGF-β subtypes were identified, with the TGF-β-high subtype being associated with a poorer prognosis and superior sensitivity to immunotherapy. Mutation analyses showed a high incidence of gene mutations in the TGF-β-high subtype. After completing signature construction, patients with colon cancer were categorized into high- and low-risk subgroups based on the median risk score of the TGF-β-related predictive signature. The risk score exhibited superior predictive performance relative to age, gender, and stage, as evidenced by its AUC of 0.686. Patients in the high-risk subgroup had higher levels of immunosuppressive cell infiltration and immune checkpoints in the TME, suggesting that these patients had better responses to immunotherapy.

Conclusions

Patients with colon cancer were divided into two subtypes with different survival and immune characteristics using consensus clustering analysis based on TGF-β signaling pathway-related genes. The constructed risk prediction signature may show promise as a biomarker for evaluating the prognosis of colon cancer, with potential utility for screening individuals for immunotherapy.

Schlagwörter

Stichwörter der Autor:innen

Colon cancerImmune microenvironmentImmunotherapyPrognosisRisk signature

Autor:innen und Institutionen

  • Department of Radiation Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China.

Förderung

  • Xi’an Jiaotong University
  • Fundamental Research Funds for the Central Universities
  • Huazhong University of Science and Technology Tongji Medical College Union Hospital
  • National Natural Science Foundation of China

Zitieren

APA

Chen, J., Ji, C., Liu, S., Wang, J., Wang, C., Pan, J., Qiao, J., Liang, Y., Cai, M., & Ma, J. (2024). Transforming growth factor-β (TGF-β) signaling pathway-related genes in predicting the prognosis of colon cancer and guiding immunotherapy. Cancer Pathogenesis and Therapy, 2(4), 299-313. https://doi.org/10.1016/j.cpt.2023.12.002

Vancouver

Chen J, Ji C, Liu S, Wang J, Wang C, Pan J, et al. Transforming growth factor-β (TGF-β) signaling pathway-related genes in predicting the prognosis of colon cancer and guiding immunotherapy. Cancer Pathogenesis and Therapy. 2024;2(4):299-313. doi:10.1016/j.cpt.2023.12.002

BibTeX
@article{Chen2024,
  author = {Chen, Jie and Ji, Chao and Liu, Silin and Wang, Jin and Wang, Che and Pan, Jue and Qiao, Jinyu and Liang, Yu and Cai, Mengjiao and Ma, Jinlu},
  title = {Transforming growth factor-β (TGF-β) signaling pathway-related genes in predicting the prognosis of colon cancer and guiding immunotherapy},
  journal = {Cancer Pathogenesis and Therapy},
  year = {2024},
  volume = {2},
  number = {4},
  pages = {299--313},
  doi = {10.1016/j.cpt.2023.12.002}
}
Kostenlos starten →